Medicare Enrolled
Dr. Scott Mink, M.D.
Hematology & Oncology · Springfield, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mink from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mink?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mink
Dr. Scott Mink is a hematology & oncology specialist in Springfield, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mink performed 128,689 Medicare services across 2,625 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mink received a total of $1,304 from 16 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mink is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in IL
$1,304 industry payments
Medicare Practice Summary
Medicare Utilization ↗128,689
Medicare services
Top 9% in IL for hematology & oncology
2,625
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,773 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
50,000 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 27,200 | $43 | $99 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
19,200 | $2 | $16 |
| BCG treatment for bladder cancer | 12,200 | $2 | $5 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,900 | $0 | $4 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,172 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,248 | $8 | $82 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,210 | $6 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,091 | $91 | $555 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,060 | $1 | $79 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
998 | $1 | $5 |
| Injection, leucovorin calcium, per 50 mg | 647 | $3 | $17 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
449 | $64 | $382 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
424 | $2 | $5 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
416 | $96 | $679 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
328 | $12 | $88 |
| Injection, granisetron hydrochloride, 100 mcg | 310 | $0 | $3 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
291 | $2 | $16 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
288 | $73 | $904 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
286 | $65 | $1,210 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
276 | $46 | $311 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
253 | $11 | $50 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 191 | $135 | $2,539 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
162 | $22 | $155 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
154 | $21 | $149 |
| Basic blood chemical test (calcium, ionized) A blood test that measures basic chemical levels, specifically including calcium and ionized calcium. |
117 | $13 | $118 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
100 | $1 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
97 | $122 | $741 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
89 | $2 | $5 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
85 | $48 | $319 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
68 | $4 | $67 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
63 | $1 | $2 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
58 | $1 | $12 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
51 | $41 | $283 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
41 | $10 | $103 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $22 | $149 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
36 | $200 | $1,130 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
33 | $38 | $178 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
32 | $1 | $5 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
29 | $5 | $58 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
85.1% medium
13.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,304
Total received (2019-2024)
Avg $261/year across 5 years
Bottom 40% in IL for hematology & oncology
16
Companies
67
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,207 (92.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$96 (7.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$783
2023
$394
2022
$31
2021
$11
2019
$85
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$220
Celgene Corporation
$122
EMD Serono, Inc.
$89
Genentech USA, Inc.
$88
Merck Sharp & Dohme LLC
$49
Gilead Sciences, Inc.
$42
AstraZeneca Pharmaceuticals LP
$35
Novartis Pharmaceuticals Corporation
$29
JAZZ PHARMACEUTICALS INC.
$22
Aveo Pharmaceuticals, Inc.
$22
Astellas Pharma US Inc
$18
ARRAY BIOPHARMA INC
$17
E.R. Squibb & Sons, L.L.C.
$17
Mirati Therapeutics, Inc.
$14
Top 3 companies account for 55.1% of 2024 payments
All-time payments by company (2019-2024) ›
Janssen Biotech, Inc.
$366
Celgene Corporation
$171
EMD Serono, Inc.
$157
Genentech USA, Inc.
$107
Gilead Sciences, Inc.
$97
AstraZeneca Pharmaceuticals LP
$79
Merck Sharp & Dohme LLC
$73
Mirati Therapeutics, Inc.
$57
AVEO Pharmaceuticals, Inc.
$47
Novartis Pharmaceuticals Corporation
$42
JAZZ PHARMACEUTICALS INC.
$22
Aveo Pharmaceuticals, Inc.
$22
Astellas Pharma US Inc
$18
ARRAY BIOPHARMA INC
$17
E.R. Squibb & Sons, L.L.C.
$17
ADC Therapeutics America, Inc.
$11
Top 3 companies account for 53.3% of all-time payments
Associated products mentioned in payments ›
Alecensa · BAVENCIO · Columvi · DARZALEX · ERLEADA · Erleada · FOTIVDA · IMFINZI · KEYTRUDA · KISQALI · KRAZATI · LYNPARZA · OPDUALAG · PIQRAY · Padcev · REBLOZYL · TECVAYLI · XALKORI · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
19
Per 100K population
9.7
County median income
$74,114
Nearest hospital
MEMORIAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mink is a mixed practice specialist, with above-average Medicare volume (top 9% in IL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mink experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Mink performed 50,000 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mink receive payments from pharmaceutical companies?
Yes. Dr. Mink received a total of $1,304 from 16 companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mink's costs compare to other hematology & oncology specialists in Springfield?
Dr. Mink's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mink) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Springfield
Browse hematology & oncology specialists in Springfield ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology